Dutasteride
FDA status: FDA has approved products that contain dutasteride, including Jalyn.
PubMed: 1,281 publications mention Dutasteride, 245 of them trials or reviews. Search PubMed
- Management of androgenic alopecia: a systematic review of the literature. Rosenthal A et al. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2024. Systematic Review. PMID 38852607 · DOI
- Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis. Lee S et al. Acta dermato-venereologica, 2019. Meta-Analysis, Systematic Review. PMID 30206635 · DOI
- Systematic review of mesotherapy: a novel avenue for the treatment of hair loss. Gupta AK et al. The Journal of dermatological treatment, 2023. Systematic Review. PMID 37558233 · DOI
- The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis. Zhou Z et al. Clinical interventions in aging, 2019. Systematic Review. PMID 30863034 · DOI
- Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis. Gupta AK et al. Journal of the European Academy of Dermatology and Venereology : JEADV, 2018. Systematic Review, Network Meta-Analysis. PMID 29797431 · DOI
ClinicalTrials.gov: 142 registered studies. See all studies
- NCT02213107 Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. (Phase 2), completed
- NCT01299571 AVODART(Dutasteride) Post-marketing Surveillance(PMS), completed
MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 228790 ↗PubChem CID 6918296 ↗Wikipedia ↗









